Influence of ST-Segment Recovery on Infarct Size and Ejection Fraction in Patients With ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 9, 2010, Pages 1223-1228

  Hallén, Jonas ^a   Sejersten, Maria ^b   Johanson, Per ^c   Atar, Dan ^a   Clemmensen, Peter M ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b Rigshospitalet   (Denmark)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRIN DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; FX 06; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 77950938829     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.034     Document Type: Article

References (19)

1. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith Jr. S.C., Anbe D.T., Kushner F.G., Ornato J.P., Pearle D.L., Sloan M.A., Jacobs A.K., Adams C.D., Anderson J.L., Buller C.E., Creager M.A., Ettinger S.M., Halperin J.L., Hunt S.A., Lytle B.W., Nishimura R., Page R.L., Riegel B., Tarkington L.G., and Yancy C.W. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 51 (2008) 210-247
2. Van de Werf F.J., Ardissino D., Betriu A., Cokkinos D.V., Falk E., Fox K.A., Julian D., Lengyel M., Neumann F.J., Ruzyllo W., Thygesen C., Underwood S.R., Vahanian A., Verheugt F.W., and Wijns W. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
3. Schroder R., Wegscheider K., Schroder K., Dissmann R., and Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 26 (1995) 1657-1664
4. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De R., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977
5. van't Hof A.W., Liem A., de Boer M.J., Zijlstra F., and Zwolle Myocardial infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
6. Matetzky S., Novikov M., Gruberg L., Freimark D., Feinberg M., Elian D., Novikov I., Di S.E., Agranat O., Har-Zahav Y., Rabinowitz B., Kaplinsky E., and Hod H. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 34 (1999) 1932-1938
7. McLaughlin M.G., Stone G.W., Aymong E., Gardner G., Mehran R., Lansky A.J., Grines C.L., Tcheng J.E., Cox D.A., Stuckey T., Garcia E., Guagliumi G., Turco M., Josephson M.E., and Zimetbaum P. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 1215-1223
8. DeLuca G., Suryapranata H., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., de Boer M.J., and van't Hof A.W. Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Heart 94 (2008) 44-47
9. Buller C.E., Fu Y., Mahaffey K.W., Todaro T.G., Adams P., Westerhout C.M., White H.D., van't Hof A.W., Van de Werf F.J., Wagner G.S., Granger C.B., and Armstrong P.W. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 118 (2008) 1335-1346
10. Atar D., Petzelbauer P., Schwitter J., Huber K., Rensing B., Kasprzak J.D., Butter C., Grip L., Hansen P.R., Suselbeck T., Clemmensen P.M., Marin-Galiano M., Geudelin B., and Buser P.T. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53 (2009) 720-729
11. Hudsmith L.E., Petersen S.E., Francis J.M., Robson M.D., and Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7 (2005) 775-782
12. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., and Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
13. Knuesel P.R., Nanz D., Wyss C., Buechi M., Kaufmann P.A., von Schulthess G.K., Luscher T.F., and Schwitter J. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108 (2003) 1095-1100
14. Nijveldt R., van der Vieuten P.A., Hirsch A., Beek A.M., Tio R.A., Tijssen J.G., Piek J.J., van Rossum A.C., and Zijlstra F. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging 2 (2009) 1187-1194
15. Sciagra R., Parodi G., Migliorini A., Valenti R., Antoniucci D., Sotgia B., and Pupi A. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy. Am J Cardiol 97 (2006) 48-54
16. Ørn S., Manhenke C., Greve O.J., Larsen A.I., Bonarjee V.V., Edvardsen T., and Dickstein K. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30 (2009) 1978-1985
17. Terkelsen C.J., and Andersen H.R. Value of ST-resolution analysis in the era of primary percutaneous coronary intervention. Heart 94 (2008) 13-15
18. Desmet W.J., Mesotten L.V., Maes A.F., Heidbuchel H.P., Mortelmans L.A., and Van de Werf F.J. Relation between different methods for analysing ST segment deviation and infarct size as assessed by positron emission tomography. Heart 90 (2004) 887-892
19. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533-1542